Search results
Novavax signs multibillion-dollar deal with Sanofi to commercialize Covid vaccine, develop...
CNBC· 17 hours agoA health worker prepares a dose of the Novavax vaccine as the Dutch Health Service Organization...
Novavax Inc (NVAX) Q1 2024 Earnings: Navigating Challenges with Strategic Partnerships and Cost ...
GuruFocus.com via Yahoo Finance· 5 hours agoIn response, Novavax is implementing cost reduction strategies aimed at significantly decreasing R&D and SG&A expenses in 2025 to below $500 million. Furthermore, the company ...
Novavax Inc (NVAX) Q1 2024 Earnings: Navigating Challenges with
Guru Focus· 5 hours agoThe company, a prominent player in the biotechnology sector focusing on the development of vaccines, reported a net loss of $147.55 million with a loss per share of $1.05.
Novavax and Sanofi Announce Co-exclusive Licensing Agreement to Co-commercialize COVID-19 Vaccine...
NBC 17 Raleigh· 17 hours ago...Agreements and in India, Japan and South Korea where Novavax has existing partnership agreements); a sole license to Novavax's adjuvanted COVID-19 vaccine for use in combination with Sanofi's flu vaccines while Novavax retains the right to and is developing its own COVID-19-Influenza Combination ...
Novavax Reports First Quarter 2024 Financial Results and Operational Highlights
CBS 47 Fresno· 17 hours agoAnnounces co-exclusive licensing agreement with Sanofi to co-commercialize COVID-19 vaccine, develop novel COVID-19-Influenza combination vaccines and develop ...
Novavax erases doubts about its ability to remain in business
Reuters via AOL· 16 hours agoIn February, Novavax had raised doubts about its ability to remain in business and announced plans...
What to know about the new 'FLiRT' COVID variants that are spreading: Your guide to the latest virus...
Yahoo Life· 4 days agoHere’s your go-to guide with everything you need to know about COVID-19, including the latest...
AstraZeneca withdraws Covid-19 jab from the market
PA Media: Science via Yahoo News· 2 days ago“The key reason for the withdrawal is likely to be that other Covid vaccines, such as Pfizer and Moderna, are essentially better products. AstraZeneca is...
The path to a better tuberculosis vaccine runs through Montana
Bozeman Daily Chronicle· 2 weeks agoA team of Montana researchers is playing a key role in the development of a more effective vaccine...
ESCMID 2024: Cutting-edge vaccines in development for a healthier tomorrow
Clinical Trials Arena via Yahoo Finance· 1 week agoDr. Mehreen Datoo of Oxford...Oxford University discussed another significant breakthrough regarding...